Lotus Biotechnology Development Corp. announced that the company has entered into an agreement with CBD SOCO to bring pharmaceutical marijuana to the thriving marketplace. Through the distribution of a new emerging treatment integrated with organic products, the company strategizes to deliver proprietary CBD derived merchandise to North American companies. The company has signed a letter of intent to own and operate an advantageous young company in southern Colorado.